MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature

Jarius, Sven; Ruprecht, Klemens; Stellmann, Jan‐Patrick; Huss, André; Ayzenberg, Ilya; Willing, Anne; Trebst, Corinna; Pawlitzki, Marc; Abdelhak, Ahmed; Grüter, Thomas; Leypoldt, Frank; Haas, Jürgen; Kleiter, Ingo; Tumani, Hayrettin; Fechner, K; Reindl, Markus; Paul, Friedemann; Wildemann, Brigitte

doi:10.1186/s12974-018-1108-6

Public

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature

Published in Journal of Neuroinflammation • Mar 19, 2018

Authors:

Sven Jarius

Klemens Ruprecht

Jan‐Patrick Stellmann

Abstract

BACKGROUND: Antibodies to human full-length myelin oligodendrocyte glycoprotein (MOG-IgG) as detected by new-generation cell-based assays have recently been described in patients presenting with acute demyelinating disease of the central nervous system, including patients previously diagnosed with m...

Subject

Multiple sclerosis

Medicine

Neurology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!